Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carnegie Investment Bank is an independent Nordic investment bank founded in Sweden with roots dating back to 1803. It offers securities brokerage/trading/research, investment banking/corporate finance advisory—including significant activity serving healthcare/life sciences clients—and private wealth management. While it plays an important role advising biotech/pharma/healthcare firms on financing/M&A deals, it is not itself a life science or health sector operating company—it does not develop therapeutics or own clinical programs. As such most fields related specifically to drug development are “null” or “not applicable.” The firm remains active with about 600 employees and SEK110bn assets under management as of recent reports, with headquarters in Stockholm and additional offices throughout the Nordics plus key international cities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carnegie Investment Bank.